| 2023-12-07 | +0.69 % |
|
| 2023-12-06 | +3.49 % |
|
| 2023-12-05 | +3.71 % |
|
| 2023-12-04 | |
|
| 2023-12-01 | +0.78 % |
|
| 2023-11-30 | +1.57 % |
|
| 2023-11-29 | -3.49 % |
|
| 2023-11-22 | +1.56 % |
|
| 2023-11-17 | +0.82 % |
|
| 2023-11-16 | -1.27 % |
|
| 2023-11-15 | +0.92 % |
|
| 2023-11-14 | +1.03 % |
|
| 2023-11-13 | +0.18 % |
|
| 2023-11-09 | -2.92 % |
|
| 2023-11-08 | -2.14 % |
|
| 2023-11-07 | -1.17 % |
|
| 2023-11-06 | +1.18 % |
|
| 2023-11-03 | +0.88 % |
|
| 2023-11-02 | +1.32 % |
- The article discusses a series of layoffs across various industries, including companies such as Panera Bread, Charles Schwab, Condé Nast, Splunk, and Ford. These layoffs are attributed to reasons such as cost-cutting initiatives, industry changes, market retraction, and macroeconomic uncertainties.
- CVS Health Corp. (CVS) stock went up by 1.32% last night. The article discusses CVS Health's strong third-quarter results, highlighting the company's diversified business model and the power of its integrated approach. CVS Health reported adjusted EPS of $2.21 and consolidated revenues of almost $90 billion, reflecting an increase of nearly 11% over the prior year. The company's performance was driven by strong performance in the Pharmacy & Consumer Wellness segment and continued momentum in the Health Services segment, offsetting Medicare Advantage medical cost pressures in the Health Care Benefits segment. CVS Health also announced the creation of Cordavis, a subsidiary focused on bringing biosimilar products to the market to lower drug costs.
- The article discusses the challenges faced by San Francisco and the inefficacy of advertising campaigns in addressing the city's problems. It mentions that businesses like Starbucks, Target, and CVS will be closing stores, and highlights the need for substantive policy changes and collaboration among influencers to bring about meaningful reform. The article does not provide a reason for the increase in CVS Health (CVS) stock.
|
| 2023-11-01 | -0.41 % |
|
| 2023-10-31 | +1.47 % |
|
| 2023-10-30 | +2.59 % |
|
| 2023-10-27 | -2.49 % |
- CVS Health (CVS) stock went down by -2.49% because the Chair, Richard Connell, resigned due to ill health, leading to uncertainty and potential disruption in the company's leadership.
- Many pharmacy employees at Walgreens and CVS are experiencing increasing workloads, understaffing, and cuts to their hours, leading to employee walkouts; these concerns have caused CVS Health (CVS) stock to go down by 2.49% as employees demand better staffing and resources to safely execute their tasks.
- The article is not about CVS Health (CVS) stock. It is about various companies in different industries, including insurance, technology, and retail, announcing layoffs and job cuts for various reasons, such as cost-cutting efforts and restructuring plans.
|
| 2023-10-26 | -0.8 % |
|
| 2023-10-25 | -0.64 % |
|
| 2023-10-24 | -0.03 % |
|
| 2023-10-23 | -0.09 % |
|
| 2023-10-20 | -2.21 % |
|
| 2023-10-19 | -0.68 % |
|
| 2023-10-17 | +0.73 % |
|
| 2023-10-16 | -0.07 % |
|
| 2023-10-13 | +0.87 % |
|
| 2023-10-12 | -1.13 % |
|
| 2023-10-11 | |
|
| 2023-10-10 | +0.67 % |
|
| 2023-10-09 | +1.93 % |
|
| 2023-10-06 | +0.22 % |
|
| 2023-10-05 | +1.12 % |
|
| 2023-10-04 | -0.39 % |
|
| 2023-10-03 | -0.63 % |
|
| 2023-09-29 | -0.3 % |
|
| 2023-09-28 | +0.36 % |
|
| 2023-09-27 | -2.17 % |
|
| 2023-09-26 | -1.71 % |
|
| 2023-09-25 | +2 % |
|
| 2023-09-22 | -1.03 % |
|
| 2023-09-21 | +0.67 % |
- The article compares Walgreens Boots Alliance (WBA) and CVS Health (CVS) as dividend stocks, highlighting the differences in their financial situations and growth strategies. While Walgreens offers a higher yield at 8.6%, investors have shown bearish sentiment due to deteriorating earnings. CVS, on the other hand, has a smaller yield at 3.5%, but with strong free cash flow and recent acquisitions, it offers a blend of income and growth potential. The reason for CVS Health stock going up is not mentioned in the article.
- CVS Health (CVS) stock went up by 0.67% after the company appointed Michael F. Mahoney, the Chairman and CEO of Boston Scientific Corporation, to serve on its Board of Directors. The appointment of a respected healthcare leader indicates CVS Health's commitment to improving health outcomes and increasing access to care for consumers.
- CVS Health (NYSE: CVS) stock went up by 0.67% due to the announcement that its board of directors has approved a quarterly dividend of $0.605 cents per share on the Common Stock of the Corporation, payable on November 1, 2023, to holders of record on October 20, 2023.
|
| 2023-09-20 | -0.81 % |
|
| 2023-09-19 | +1.82 % |
|
| 2023-09-18 | -0.24 % |
|
| 2023-09-15 | +1.32 % |
|
| 2023-09-14 | -0.41 % |
|
| 2023-09-13 | -0.4 % |
- CVS Health (CVS) stock went down by 0.4% last night as drugstore chains CVS Health and Walgreens Boots Alliance announced the availability of updated COVID-19 vaccines in their stores, with shots already being delivered in some locations on Wednesday. The decline in stock may be attributed to decreased demand for vaccines since the U.S. government ended the COVID public health emergency declaration and transferred vaccination responsibility to the private sector.
- The article discusses Michael Burry's investments, including a $4 million stake in Geo Group and his portfolio allocation. CVS Health Group is mentioned as one of the noteworthy positions in his portfolio. The article does not provide a reason for the decline in CVS Health stock.
- The article lists a series of large corporate layoffs that have taken place over the past couple of months in various industries, with companies such as Binance.US, CVS Health, Roku, Farmers Insurance, and T-Mobile among those making cuts; CVS Health had announced plans to cut around 5,000 of its more than 300,000 employees, primarily affecting corporate positions, in an effort to improve profitability.
|
| 2023-09-12 | +2.57 % |
|
| 2023-09-11 | +4.42 % |
|
| 2023-09-08 | +0.37 % |
|
| 2023-09-07 | +0.14 % |
|
| 2023-09-06 | -0.15 % |
|
| 2023-09-05 | -0.09 % |
|
| 2023-09-01 | +0.77 % |
|
| 2023-08-31 | -2.48 % |
|
| 2023-08-29 | -0.16 % |
|
| 2023-08-25 | +1.25 % |
|
| 2023-08-24 | +0.14 % |
|
| 2023-08-23 | -0.97 % |
|
| 2023-08-22 | -0.04 % |
|
| 2023-08-21 | +0.4 % |
|
| 2023-08-18 | +0.01 % |
|
| 2023-08-17 | -8.14 % |
|
| 2023-08-16 | -0.83 % |
|
| 2023-08-14 | -0.71 % |
- The article discusses the potential decline in demand for the new COVID vaccine, which is set to be released next month, leading to a decrease in the stock price of CVS Health (CVS). The declining concern about the virus, fatigue, and skepticism about the vaccine are cited as reasons for the expected decrease in demand for the vaccine. Additionally, Pfizer and Moderna, the leading vaccine makers, have lowered their expectations for the vaccination campaign this fall. The article suggests that public health officials will need to make the case to the American public that COVID-19 still poses a risk in order to encourage vaccination.
- The article discusses how Michael Burry's Scion Asset Management sold its stakes in Alibaba and JD.com, which were its top holdings, in the second quarter, leading to a decline in the stocks of those companies, and also mentions that Scion added shares of CVS Health Corp., among other new stakes.
- The article provides an update on Else Nutrition Holdings Inc.'s second quarter 2023 financial results and highlights its expansion in the plant-based nutrition market, including partnerships with retailers such as Walmart, CVS, and Shoppers Drug Mart; the company's focus on expense management and capital efficiency; and its progress in obtaining FDA and regulatory approvals for its plant-based infant formula. There is no mention of CVS Health (CVS) stock going down in the article, so the reason for the stock's decline is not provided.
|
| 2023-08-11 | +1.23 % |
- The article discusses two healthcare companies, CVS Health and Viatris, that could be attractive picks for dividend investors. CVS Health's stock has gone up by 1.23% recently despite a decline earlier in the year, partly due to its solid performance in the second quarter and its attractive valuation with a low forward P/E ratio. Viatris, on the other hand, has underperformed the market since its IPO but has potential for growth with its portfolio of generics and efforts to decrease costs and boost efficiency. Both companies offer attractive dividend yields.
- CVS Health (CVS) stock went up by 1.23% last night, and the article does not provide specific information as to why this occurred.
- CVS Health (CVS) stock went up by 1.23% last night, despite the fact that insiders have been selling more stock than they have bought, which is generally seen as a negative sign. However, the company does have a high level of insider ownership, suggesting that management incentives are aligned with shareholders. The article advises investors to be cautious and consider the risks before making any investment decisions.
|
| 2023-08-10 | -0.86 % |
|
| 2023-08-09 | +0.81 % |
|
| 2023-08-08 | +0.12 % |
|
| 2023-08-07 | +1.4 % |
|
| 2023-08-04 | -1.92 % |
|
| 2023-08-03 | -2.74 % |
|
| 2023-08-02 | +3.33 % |
|
| 2023-08-01 | -0.99 % |
|
| 2023-07-31 | +0.11 % |
|
| 2023-07-28 | -1.14 % |
|
| 2023-07-26 | -0.74 % |
|
| 2023-07-24 | +1.2 % |
|
| 2023-07-21 | +0.24 % |
|
| 2023-07-20 | +0.66 % |
|
| 2023-07-19 | +2.86 % |
|
| 2023-07-18 | +1.6 % |
|
| 2023-07-17 | -0.29 % |
|
| 2023-07-14 | +0.22 % |
|
| 2023-07-12 | -1.12 % |
|
| 2023-07-11 | +2.75 % |
|
| 2023-07-10 | +0.27 % |
|
| 2023-07-07 | -0.53 % |
|
| 2023-07-06 | -0.07 % |
|
| 2023-07-05 | -0.26 % |
|
| 2023-07-03 | +0.93 % |
|
| 2023-06-30 | +0.54 % |
|
| 2023-06-26 | +0.36 % |
|
| 2023-06-22 | +0.93 % |
|
| 2023-06-21 | +0.15 % |
|
| 2023-06-20 | +1.4 % |
|
| 2023-06-16 | -2.56 % |
|
| 2023-06-14 | -7.76 % |
|
| 2023-06-13 | +1.06 % |
|
| 2023-06-12 | -0.36 % |
|
| 2023-06-09 | +0.01 % |
- Walgreens Boots Alliance has sold its remaining stake in home infusion services provider Option Care Health, raising $330m, which it plans to use “primarily for debt pay down, continued support of WBA’s strategic priorities and transformation to a consumer-centric healthcare company”, with the company having been reducing its stake in other businesses under CEO Roz Brewer in recent years to raise money for high-priority areas such as Walgreens' multi-billion dollar bet on doctor-staffed primary care clinics attached to drugstores, with this movement into healthcare services seen not only at Walgreens, but across retail pharmacy chains including Walmart, CVS Health and Amazon.
- CVS Health (CVS) stock was up by 0.01% due to the final approval of settlement agreements for $17.3 billion with drug store chains and drug makers including CVS Health and Allergan for opioid abatement, education, and treatment efforts for communities.
- CVS Health (CVS) stock rose by 0.01% as part of an all-around favorable trading session for the stock market, with the S&P 500 Index and Dow Jones Industrial Average rising, but the article does not provide a specific reason for the increase.
|
| 2023-06-08 | +0.38 % |
|
